213 related articles for article (PubMed ID: 17578166)
1. [Adiponectin and atherosclerosis].
Haluzíková D; Roubícek T; Haluzík M
Vnitr Lek; 2007 Apr; 53(4):359-63. PubMed ID: 17578166
[TBL] [Abstract][Full Text] [Related]
2. [Adiponectin and its role in the pathogenesis of obesity, diabetes mellitus and insulin resistance].
Owecki M; Sowiński J
Pol Merkur Lekarski; 2006 Mar; 20(117):355-7. PubMed ID: 16780274
[TBL] [Abstract][Full Text] [Related]
3. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
Kieć-Klimczak M; Malczewska-Malec M; Huszno B
Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
[TBL] [Abstract][Full Text] [Related]
4. Metabolic actions of adipocyte hormones: focus on adiponectin.
Ahima RS
Obesity (Silver Spring); 2006 Feb; 14 Suppl 1():9S-15S. PubMed ID: 16642957
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin, obesity and atherosclerosis.
Behre CJ
Scand J Clin Lab Invest; 2007; 67(5):449-58. PubMed ID: 17763181
[TBL] [Abstract][Full Text] [Related]
6. The endocrine function of adipose tissue: an update.
Ronti T; Lupattelli G; Mannarino E
Clin Endocrinol (Oxf); 2006 Apr; 64(4):355-65. PubMed ID: 16584505
[TBL] [Abstract][Full Text] [Related]
7. Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy.
Tankó LB; Christiansen C
Climacteric; 2006 Jun; 9(3):169-80. PubMed ID: 16766431
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond.
Lu JY; Huang KC; Chang LC; Huang YS; Chi YC; Su TC; Chen CL; Yang WS
J Biomed Sci; 2008 Sep; 15(5):565-76. PubMed ID: 18535923
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
Lara-Castro C; Fu Y; Chung BH; Garvey WT
Curr Opin Lipidol; 2007 Jun; 18(3):263-70. PubMed ID: 17495599
[TBL] [Abstract][Full Text] [Related]
10. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin in health and disease.
Oh DK; Ciaraldi T; Henry RR
Diabetes Obes Metab; 2007 May; 9(3):282-9. PubMed ID: 17391153
[TBL] [Abstract][Full Text] [Related]
12. Metabolic effects associated with adipose tissue distribution.
Zahorska-Markiewicz B
Adv Med Sci; 2006; 51():111-4. PubMed ID: 17357288
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular actions of adiponectin: pathophysiologic implications.
Maia-Fernandes T; Roncon-Albuquerque R; Leite-Moreira AF
Rev Port Cardiol; 2008 Nov; 27(11):1431-49. PubMed ID: 19227810
[TBL] [Abstract][Full Text] [Related]
14. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases.
Tilg H; Moschen AR
Clin Sci (Lond); 2008 Feb; 114(4):275-88. PubMed ID: 18194136
[TBL] [Abstract][Full Text] [Related]
15. [The role of the fat tissue and its hormones in the mechanisms of insulin resistance and the development of type 2 diabetes mellitus].
Klebanova EM; Balabolkin MI; Kreminskaia VM
Klin Med (Mosk); 2007; 85(7):20-7. PubMed ID: 17882804
[TBL] [Abstract][Full Text] [Related]
16. The role of adiponectin in obesity, diabetes, and cardiovascular disease.
Kawano J; Arora R
J Cardiometab Syndr; 2009; 4(1):44-9. PubMed ID: 19245516
[TBL] [Abstract][Full Text] [Related]
17. [The role of leptin, adiponectin and insulin-resistance markers in development of early stages of chronic kidney disease and atherosclerosis of carotid arteries in obese patients].
Saginova EA; Galliamov MG; Severova MM; Surkova OA; Fomin VV; Ermakov NV; Rodina AV; Mukhin NA
Ter Arkh; 2011; 83(6):47-53. PubMed ID: 21786576
[TBL] [Abstract][Full Text] [Related]
18. The role of adiponectin in metabolic and vascular disease: a review.
Cui J; Panse S; Falkner B
Clin Nephrol; 2011 Jan; 75(1):26-33. PubMed ID: 21176748
[TBL] [Abstract][Full Text] [Related]
19. Regulation of adiponectin release and demonstration of adiponectin mRNA as well as release by the non-fat cells of human omental adipose tissue.
Fain JN; Buehrer B; Tichansky DS; Madan AK
Int J Obes (Lond); 2008 Mar; 32(3):429-35. PubMed ID: 17895880
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance.
Haluzik M
Curr Opin Investig Drugs; 2005 Oct; 6(10):988-93. PubMed ID: 16259219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
